These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3538178)

  • 1. All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality.
    Langford HG; Stamler J; Wassertheil-Smoller S; Prineas RJ
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):29-54. PubMed ID: 3538178
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group.
    Prev Med; 1985 May; 14(3):312-35. PubMed ID: 2865725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the Hypertension Detection and Follow-up Program. The Hypertension Detection and Follow-up Program Cooperative Group.
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):3-10. PubMed ID: 3538179
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program.
    Curb JD; Maxwell MH; Schneider KA; Taylor JO; Shulman NB
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):73-88. PubMed ID: 3538181
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicians' interpretation of the results and implications of the Hypertension Detection and Follow-up Program.
    Cressman MD; Gifford RW
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):89-97. PubMed ID: 3538182
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrovascular events in the Hypertension Detection and Follow-up Program.
    Daugherty SA; Berman R; Entwisle G; Haerer AF
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):63-72. PubMed ID: 3538180
    [No Abstract]   [Full Text] [Related]  

  • 7. The Hypertension Detection and Follow-up Program design, methods, and baseline characteristics and blood pressure response of the study population.
    Davis BR; Ford CE; Remington RD; Stamler R; Hawkins CM
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):11-28. PubMed ID: 3538177
    [No Abstract]   [Full Text] [Related]  

  • 8. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. 1979.
    JAMA; 1997 Jan; 277(2):157-66. PubMed ID: 8990344
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program.
    Borhani NO; Blaufox MD; Oberman A; Polk BF
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):55-62. PubMed ID: 2947267
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project.
    Siegel D; Kuller L; Lazarus NB; Black D; Feigal D; Hughes G; Schoenberger JA; Hulley SB
    Am J Epidemiol; 1987 Sep; 126(3):385-99. PubMed ID: 3303916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of clinical trials regarding the efficacy of treating hypertension.
    Borhani NO
    Clin Geriatr Med; 1989 Nov; 5(4):675-90. PubMed ID: 2691058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group.
    JAMA; 1988 Apr; 259(14):2113-22. PubMed ID: 3346988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials of the treatment of mild hypertension. An interim analysis.
    Lancet; 1982 Jan; 1(8264):149-56. PubMed ID: 6119523
    [No Abstract]   [Full Text] [Related]  

  • 14. Mortality in various intervention trials in elderly hypertensive patients: a review.
    Staessen J; Fagard R; Van Hoof R; Amery A
    Eur Heart J; 1988 Feb; 9(2):215-22. PubMed ID: 3280319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypertension detection and follow-up program: 17 years on.
    Ramsay LE
    JAMA; 1997 Jan; 277(2):167-70. PubMed ID: 8990345
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment trials in hypertension: a review.
    Cutler JA; Furberg CD
    Prev Med; 1985 Jul; 14(4):499-518. PubMed ID: 3906629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should mild hypertension be treated?
    Borhani NO
    Contrib Nephrol; 1982; 33():239-49. PubMed ID: 6749420
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
    Shulman NB; Ford CE; Hall WD; Blaufox MD; Simon D; Langford HG; Schneider KA
    Hypertension; 1989 May; 13(5 Suppl):I80-93. PubMed ID: 2490833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The problem of treatment in mild hypertension.
    Peart WS
    Br J Clin Pharmacol; 1982 Jan; 13(1):87-90. PubMed ID: 7039649
    [No Abstract]   [Full Text] [Related]  

  • 20. The mild hypertension dilemma: results of the British MRC trial.
    Miall WE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):12S-21S. PubMed ID: 3098929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.